A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

Recruiting

Phase 1

CagrilintideA Study on How NNC0174-1213 Works in People With Overweight or Obesity.

Sponsor:

Novo Nordisk A/S

Code:

NCT06719011

Conditions

Obesity

Overweight

Eligibility Criteria

Sex: Male

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

NNC0174-1213 A

Cagrilintide B

Placebo A (NNC0174 1213 A)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by Novo Nordisk A/S on 2024-12-20.